Dec 15, 2013 by DAVE MIHALOVIC
Utah Public Health Bans Gardasil Vaccine
Citing low demand, high costs - and questioning the benefits, Utah’s Public Department of Health does not stock or recommend Gardasil HPV vaccine. The decision to exclude the vaccine from its public health clinics was made by the agency’s director, contrary to the area's Board of Health.
“The backlash and sentiment against it was strong enough that there’s no reason to go there,” physician David Blodgett explained. “No one wants it and it’s too expensive when we’re not funded to provide it.”
The vaccine isn’t mandated in Utah. But the Utah Department of Health has been recommending it for preteen girls since 2006, and for boys since 2011.
At 42 percent, Utah ranks lowest in the nation for completion of the three-injection series among girls who start it.
Unproven Science and Increasing Reports of Side Effects
Official reasons for the slow uptake are varied, but informed parents who have increasingly become skeptical of vaccination, especially the HPV vaccine are likely making the difference.
Just a few months ago, hundreds of adverse reactions from the cervical cancer vaccine in Japan caused vaccine injuries and disability in many teenagers courtesy of Cervarix and Gardasil HPV injections. In July, 2013, the Japanese health ministry issued a nationwide notice that cervical cancer vaccinations should no longer be recommended in Japan. Japanese teens who received the vaccines are now in wheelchairs with damage to their brains and spinal cord.
The HPV vaccine is possibly the biggest vaccine hoax in the last century. HPV vaccines are nothing more than a worldwide exercise in profiteering at the expense of children's health. Due to the overwhelming amount of side effects associated with the vaccine, health agencies are now encouraging health professionals not to report adverse reactions, a clear indication that something is very wrong.
Earlier this month, Mr. Jean-Christophe Coubris, defence lawyer for Marie-Oceane, a HPV vaccine injured teen, has filed charges with the French public prosecutor in Bobigny, in the outskirts of Paris, against both Laboratoire Sanofi Pasteur MSD and the French authority Agence Nationale du Medicament (ANSM), the French National Medicines Agency, for breach of their manifest duty to ensure safety and for disregard of the precautionary and prevention principles.
“To be dissuaded by cost issues, or to not stock the vaccine due to low public demand, is disingenuous, especially for someone with responsibilities to protect the public,” said said William Cosgrove, a pediatrician in Murray and a member of the Utah Scientific Immunization Advisory Committee. “I believe the real medical issues here are clouded by a moralistic belief system that precludes any frank discussion about sexuality in adolescents.”
Blodgett cites other problems with Gardasil, namely that it was fast-tracked through the Food and Drug Administration (FDA) and a belief that its benefits were oversold by drug maker Merck.
Thanks to the wealth of information available on the HPV vaccine, the proportion of insured girls and young women completing the human papillomavirus (HPV) vaccine among those who initiated the series has dropped significantly -- as much as 63 percent -- since the vaccine was approved in 2006, according to new research from the University of Texas Medical Branch (UTMB) in Galveston.
The study, published in Cancer, reveals the steepest decline in vaccine completion among girls and young women aged nine to 18 -- the age group according to medical officials that should receive the vaccine in three doses over six months -- a message that has been drilled into parents for just over five years.
“The science wasn’t good... We had physicians in our community arguing that we not make it available,” said Blodgett.
Just two years ago, a publication in the Annals of Medicine exposed the fraudulent nature of Human papillomavirus (HPV) vaccines. Key messages the researchers report include a lack of evidence for any HPV vaccines in preventing cervical cancer and lack of evaluation of health risks. The researchers stated that physicians should adopt a more rigorous evidence-based medicine approach, in order to provide a balanced and objective evaluation of vaccine risks and benefits to their patients.
The Public Isn't Buying Medical Hype
It’s not the only risk and the vaccine is claimed to cut the risk by only 17 percent. Cancers caused by HPV are extremely rare and vaccination comes with no guarantee for long-term protection and high risk of side effects.
Weighed against the vaccine’s risks, “the public isn’t buying it,” said Blodgett. “It’s eroding public trust in immunization programs.”
“It’s a complicated vaccine that requires discussion about [sexual health] and a physical exam and follow-up visits with a doctor,” said the agency’s director, Joseph Shaffer. “My feeling is that’s better held in the physician’s office than here at the health department.”
Fear that Gardasil is dangerous hasn’t been eased by the FDA’s assurances. The agency approved and monitors the drug and says its safety profile matches those of other vaccines, but the evidence that continues to coming forward from the U.S. and around the world are proving different.
Earlier this month, national talk show host Katie Couric featured a woman on daytime TV who said the HPV vaccine killed her daughter. The show was roundly criticized by other media, including Slate and Forbes magazine.
Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.